Lanfear Dennis M
Officer at CHRS
- Sold, on record
- $17.2M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Nov 22, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CHRSCoherus Oncology, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CHRSPlan not statedSep 21, 2016 2016
Sold 4,060 shares at $31.75 ($129k)
Lanfear Dennis M, President and CEO
Sold 0.3% of holdings ($42.6M position)1.3M shares leftFiling
- 2 Form 4 sale CHRSPlan not statedMay 16, 2018 +602 days
Sold 20,984 shares at $16.26 ($341k)
Lanfear Dennis M, Officer, Director
Sold 1.6% of holdings ($21.7M position)1.3M shares leftFiling
- 3 Form 4 sale CHRSPlan not statedMay 30, 2019 +379 days
Sold 32,398 shares at $19.49 ($631k)
Lanfear Dennis M, President & CEO
Sold 2.5% of holdings ($25.7M position)1.3M shares leftFiling
- 4 Form 4 sale CHRSUnusualNov 20, 2019 +174 days
Sold 825,000 shares at $18.00 ($14.8M)
Lanfear Dennis M, President & CEO
Sold 64.2% of holdings ($23.1M position)459,184 shares leftFiling
- 5 Form 4 sale CHRSPlan not statedNov 21, 2019 +1 day
Sold 12,500 shares at $18.56 ($232k)
Lanfear Dennis M, President & CEO
Sold 2.7% of holdings ($8.5M position)446,684 shares left0.4x usual sizeFiling
- 6 Form 4 sale CHRSPlan not statedJun 8, 2021 +565 days
Sold 31,054 shares at $13.56 ($421k)
Lanfear Dennis M, President & CEO
Sold 5.9% of holdings ($7.1M position)493,258 shares leftFiling
- 7 Form 144 notice CHRSNoticeNov 22, 2023 +897 days
Filed to sell 223,100 shares ($450k)
Lanfear Dennis M, Officer
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale CHRSNo planNov 22, 2023 same day
Sold 223,100 shares at $2.02 ($451k)
Lanfear Dennis M, President & CEO
No 10b5-1 planSold 23.4% of holdings ($1.9M position)731,693 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | Nov 24, 2023 | CHRS | President & CEO | Form 4 sale | 223,100 | $451k | 23.4% | No plan | SEC |
| Nov 22, 2023 | Nov 22, 2023 | CHRS | Officer | Form 144 notice | 223,100 | $450k | Notice | SEC | |
| Jun 8, 2021 | Jun 8, 2021 | CHRS | President & CEO | Form 4 sale | 31,054 | $421k | 5.9% | Plan not stated | SEC |
| Nov 21, 2019 | Nov 25, 2019 | CHRS | President & CEO | Form 4 sale | 12,500 | $232k | 2.7% | Plan not stated | SEC |
| Nov 20, 2019 | Nov 22, 2019 | CHRS | President & CEO | Form 4 sale | 825,000 | $14.8M | 64.2% | Unusual | SEC |
| May 30, 2019 | May 31, 2019 | CHRS | President & CEO | Form 4 sale | 32,398 | $631k | 2.5% | Plan not stated | SEC |
| May 16, 2018 | May 17, 2018 | CHRS | Officer, Director | Form 4 sale | 20,984 | $341k | 1.6% | Plan not stated | SEC |
| Sep 21, 2016 | Sep 22, 2016 | CHRS | President and CEO | Form 4 sale | 4,060 | $129k | 0.3% | Plan not stated | SEC |
| Sep 16, 2016 | Sep 20, 2016 | CHRS | President and CEO | Form 4 sale | 2,900 | $92k | 0.2% | Plan not stated | SEC |
| Nov 30, 2015 | Dec 2, 2015 | CHRS | President and CEO | Form 4 sale | 400 | $13k | 0.0% | Plan not stated | SEC |